NASDAQ:INMB
Inmune Stock News
$11.18
-0.0200 (-0.179%)
At Close: May 07, 2024
INmune Bio GAAP EPS of -$1.88 misses by $1.30, revenue of $0.18M
09:03pm, Thursday, 03'rd Mar 2022 Seeking Alpha
INmune Bio press release (INMB): Q4 GAAP EPS of -$1.88 misses by $1.30.Revenue of $0.18M (+63.6% Y/Y).
INmune Bio, Inc. to Report Fourth Quarter 2021 Financial Results and Provide a Corporate Update on Thursday, March 3
09:00am, Wednesday, 23'rd Feb 2022
Management to host conference call and webcast at 4:30 pm ET on that day
INmune Bio, Inc. to Present at the BIO CEO & Investor Conference
09:00am, Tuesday, 08'th Feb 2022
BOCA RATON, Florida., Feb. 08, 2022 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company focused on developing treatments that harness the pa
INmune Bio, The Biotech In My Stable For After Cassava Sciences
04:23pm, Monday, 17'th Jan 2022 Seeking AlphaINmune Bio, The Biotech In My Stable For After Cassava Sciences
11:23am, Monday, 17'th Jan 2022
Both Cassava Sciences and INmune Bio have brought impressive results on neuroinflammation and neurodegeneration. I expect INmune Bio's XPro to yield impressive results in its phase 2 trials like Cassa
INmune Bio, Inc. to Participate in January Investor Conferences and a Medical Meeting
09:00am, Tuesday, 04'th Jan 2022
Boca Raton, Florida, Jan. 04, 2022 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company focused on developing treatments that harness the p
INmune Bio, Inc. (NASDAQ:INMB) Expected to Post Earnings of -$0.56 Per Share
08:16am, Sunday, 12'th Dec 2021 Dakota Financial News
Analysts forecast that INmune Bio, Inc. (NASDAQ:INMB) will post earnings per share of ($0.56) for the current quarter, according to Zacks Investment Research. Zero analysts have made estimates for INmune Bios earnings. INmune Bio reported earnings of ($0.24) per share during the same quarter last year, which would indicate a negative year-over-year growth rate of []
INmune Bio (NASDAQ:INMB) Downgraded by Zacks Investment Research
11:28am, Sunday, 14'th Nov 2021 Dakota Financial News
Zacks Investment Research cut shares of INmune Bio (NASDAQ:INMB) from a hold rating to a sell rating in a report issued on Thursday morning, Zacks.com reports. According to Zacks, INmune Bio Inc. is a clinical-stage biotechnology company. It engages in developing therapies targeting the innate immune system in cancer. The companys product platform consists of []
INmune Bio, Inc. (INMB) CEO R. J. Tesi on Q3 2021 Results - Earnings Call Transcript
01:14am, Thursday, 04'th Nov 2021
INmune Bio, Inc. (INMB) CEO R. J. Tesi on Q3 2021 Results - Earnings Call Transcript
INmune Bio, Inc. to Report Third Quarter 2021 Financial Results and Provide a Corporate Update on Wednesday, November 3
09:00am, Monday, 25'th Oct 2021
Management to host conference call and webcast at 4:30 pm ET on that day Management to host conference call and webcast at 4:30 pm ET on that day
INmune Bio A No-Brainer Investment
05:44pm, Wednesday, 13'th Oct 2021
GameStop stock continues to defy the Street logic. Its fans are willing to stick around with Ryan Cohen & Co. for the long term. Matt Furlong & the team did not announce anything substantial on its re
INmune Bio, Inc. to Participate in the B. Riley Fall 2021 Best Ideas in Oncology Series
04:00pm, Monday, 27'th Sep 2021
Boca Raton, FL, Sept. 27, 2021 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (the, “Company”), a clinical-stage immunology company focused on developing treatments that harness the patient
INmune Bio, Inc. Announces Participation at Upcoming Investor Conferences
04:00pm, Monday, 20'th Sep 2021
BOCA RATON, Florida, Sept. 20, 2021 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company focused on developing treatments that harness the
INMB Stock: Explanation For Over 30% Increase This Week
10:56am, Thursday, 02'nd Sep 2021
The stock price of INmune Bio Inc (NASDAQ: INMB) increased by over 30% this week. This is why it happened.
Why Are Shares Of INmune Bio Trading Higher Wednesday Afternoon?
04:45pm, Wednesday, 01'st Sep 2021
INmune Bio, Inc. (NASDAQ: INMB) shares traded higher Wednesday afternoon following data out of a trial for the company's Alzheimer's drug candidate. The company said its selective dominant-negative tu